Axonics Inc (AXNX)
67.28
+0.17
(+0.25%)
USD |
NASDAQ |
May 03, 16:00
67.24
-0.04
(-0.06%)
After-Hours: 20:00
Axonics Research and Development Expense (Quarterly): 11.06M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.06M |
| December 31, 2023 | 9.714M |
| September 30, 2023 | 8.167M |
| June 30, 2023 | 8.949M |
| March 31, 2023 | 8.056M |
| December 31, 2022 | 8.103M |
| September 30, 2022 | 7.936M |
| June 30, 2022 | 7.135M |
| March 31, 2022 | 11.24M |
| December 31, 2021 | 10.18M |
| September 30, 2021 | 8.648M |
| June 30, 2021 | 9.098M |
| March 31, 2021 | 9.369M |
| December 31, 2020 | 8.111M |
| Date | Value |
|---|---|
| September 30, 2020 | 7.719M |
| June 30, 2020 | 6.37M |
| March 31, 2020 | 6.855M |
| December 31, 2019 | 6.118M |
| September 30, 2019 | 4.855M |
| June 30, 2019 | 4.874M |
| March 31, 2019 | 4.219M |
| December 31, 2018 | 4.783M |
| September 30, 2018 | 3.898M |
| June 30, 2018 | 6.178M |
| March 31, 2018 | 4.543M |
| December 31, 2017 | 3.373M |
| September 30, 2017 | 3.132M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
4.855M
Minimum
Sep 2019
11.24M
Maximum
Mar 2022
8.128M
Average
8.107M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 366.00M |
| Cutera Inc | 4.564M |
| Stereotaxis Inc | 2.212M |
| Electromed Inc | 0.107M |
| Myomo Inc | 0.878M |